CSIMarket
 


Apyx Medical Corporation  (APYX)
Other Ticker:  
 
 

APYX's Net Cash Flow Growth by Quarter and Year

Apyx Medical's Net Cash Flow results by quarter and year




APYX Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 21.52 -4.64 -0.03 -1.62
III Quarter September 3.66 -5.23 -3.77 -2.62
II Quarter June 2.22 -6.17 -4.87 -5.22
I Quarter March 6.06 -4.64 -2.38 -7.43
FY   33.46 -20.68 -11.05 -16.89



APYX Net Cash Flow fourth quarter 2023 Y/Y Growth Comment
Apyx Medical Corporation in the fourth quarter 2023 achieved Net Cash Flow of $ 21.52 millions compare to net cash outflow recorded in same quarter a year ago.

According to the results reported in the fourth quarter 2023, Apyx Medical Corporation achieved the best Net Cash Flow growth in Medical Equipment & Supplies industry. While Apyx Medical Corporation' s Net Cash Flow no change of % ranks overall at the positon no. 111 in the fourth quarter 2023.




APYX Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Apyx Medical's fourth quarter 2023 Net Cash Flow $ 21.52 millions APYX's Income Statement
Apyx Medical's fourth quarter 2022 Net Cash Flow $ -4.64 millions Quarterly APYX's Income Statement
New: More APYX's historic Net Cash Flow Growth >>


APYX Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December 487.92 % - - -
III Quarter September 64.86 % - - -
II Quarter June -63.37 % - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #1
Healthcare Sector #11
Overall #111

Net Cash Flow Y/Y Growth Statistics
High Average Low
-3.4 % -137.55 % -270.01 %
(Sep. 30, 2014)   (Dec 31 2017)
Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #1
Healthcare Sector #11
Overall #111
Net Cash Flow Y/Y Growth Statistics
High Average Low
-3.4 % -137.55 % -270.01 %
(Sep. 30, 2014)   (Dec 31 2017)

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Apyx Medical's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
102440 % 20565.95 % -100 %
(Dec 31 2016)  


APYX's IV. Quarter Q/Q Net Cash Flow Comment
Apyx Medical Corporation achieved in the IV. Quarter 2023 below company average Net Cash Flow doubling of 487.92% quarter on quarter, to $ 21.52 millions.

Albeit the IV. Quarter 2023 Apyx Medical's Net Cash Flow quarter on quarter growth was below the average of 20565.95 %, that was yet encouraging news, as the IV. Quarter expension, eclipses the % Net Cash Flow rise in the same quarter a year ago

Within Medical Equipment & Supplies industry 2 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Apyx Medical's Net Cash Flow growth quarter on quarter, overall rank is 115.


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #3
Healthcare Sector #15
Overall #115
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #3
Healthcare Sector #15
Overall #115
Net Cash Flow Q/Q Growth Statistics
High Average Low
102440 % 20565.95 % -100 %
(Dec 31 2016)  


APYX's IV. Quarter Q/Q Net Cash Flow Comment
Apyx Medical Corporation achieved in the IV. Quarter 2023 below company average Net Cash Flow doubling of 487.92% quarter on quarter, to $ 21.52 millions.

Even if the IV. Quarter 2023 APYX's Net Cash Flow Q/Q growth was below the regular , this was yet good sign, as the current improvement, transcends the % surge in the same quarter a year ago

Within Medical Equipment & Supplies industry 2 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Apyx Medical's Net Cash Flow growth quarter on quarter, overall rank is 115.


Apyx Medical's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Cash Flow 12 Months Ending $ 33.46 $ 7.30 $ -1.58 $ -9.98 $ -20.68
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) 358.29 % - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 111 # 0 # 0 # 0 # 0




Cumulative Net Cash Flow growth Comment
In the Dec 31 2023 period, Apyx Medical had cumulative twelve months Net Cash Flow of $ 33 millions compare to net cash outflow of $ -21 millions a year ago.
Besides Medical Equipment & Supplies company has restored the prosperity, Apyx Medical by this time is heading full steam and showing above average Net Cash Flow gain, from the twelve months ending in the quarter before of 358.29 % from $7.3 millions.

Apyx Medical Corporation achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
-3.4 %
-137.55 %
-270.01 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 11
S&P 500 # 111
Cumulative Net Cash Flow growth Comment
In the Dec 31 2023 period, Apyx Medical had cumulative twelve months Net Cash Flow of $ 33 millions compare to net cash outflow of $ -21 millions a year ago.
Not only that Apyx Medical has regained the bottom-line, the company is already gaining momentum with above normal Net Cash Flow surge, from the twelve months ending in the quarter before of 358.29 % from $7.3 millions.

Apyx Medical Corporation achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
-3.4 %
-137.55 %
-270.01 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 11
S&P 500 # 111




Other Net Cash Flow Growth
Medical Equipment & Supplies Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
APYX's Net Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for APYX's Competitors
Net Cash Flow Growth for Apyx Medical's Suppliers
Net Cash Flow Growth for APYX's Customers

You may also want to know
APYX's Annual Growth Rates APYX's Profitability Ratios APYX's Asset Turnover Ratio APYX's Dividend Growth
APYX's Roe APYX's Valuation Ratios APYX's Financial Strength Ratios APYX's Dividend Payout Ratio
APYX's Roa APYX's Inventory Turnover Ratio APYX's Growth Rates APYX's Dividend Comparisons



Companies with similar Net Cash Flow doubling for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2023
Astrazeneca Plc-5.29%$ -5.287 millions
Lipocine Inc -6.98%$ -6.984 millions
Caredx Inc -14.62%$ -14.617 millions
Sophia Genetics Sa-16.41%$ -16.406 millions
Xencor Inc-17.78%$ -17.780 millions
Kronos Bio Inc -20.78%$ -20.784 millions
Earth Science Tech Inc -21.38%$ -21.381 millions
Hookipa Pharma inc -22.19%$ -22.193 millions
Anaptysbio Inc -24.22%$ -24.222 millions
Koru Medical Systems Inc-26.57%$ -26.570 millions
Abbott Laboratories-35.07%$ -35.069 millions
Lantheus Holdings Inc -37.16%$ -37.161 millions
Alcon inc -37.78%$ -37.778 millions
Inflarx N v -38.04%$ -38.037 millions
Novartis Ag-39.41%$ -39.413 millions
Argenx se-40.00%$ -40.005 millions
Gh Research Plc-40.04%$ -40.040 millions
Bright Minds Biosciences Inc -41.15%$ -41.154 millions
Enzon Pharmaceuticals inc -42.33%$ -42.332 millions
Myriad Genetics Inc -44.65%$ -44.653 millions
Elutia inc -46.46%$ -46.456 millions
Gilead Sciences Inc -46.70%$ -46.704 millions
Koninklijke Philips Nv-49.11%$ -49.110 millions
Avidity Biosciences Inc -49.45%$ -49.449 millions
Proqr Therapeutics N v -49.46%$ -49.460 millions
Protalix Biotherapeutics inc -49.52%$ -49.523 millions
Xeris Biopharma Holdings Inc -49.99%$ -49.994 millions
Altair International Corp -52.34%$ -52.344 millions
Macrogenics Inc -55.57%$ -55.574 millions
Atricure Inc -59.98%$ -59.983 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com